Skip to main content
. Author manuscript; available in PMC: 2009 Jan 23.
Published in final edited form as: Brain Res. 2007 Nov 17;1190:15–22. doi: 10.1016/j.brainres.2007.11.015

Table 1.

Transduction and toxicity of AAV serotypes on cultured neurons at 2 weeks post-transduction

Serotype Dose (GC) Percent Transduction (GFP+/DAPI+) Total Cells Counted (n) Cultures (n) Percent of transduced cells that are neurons (MAP2+GFP+/GFP+) Total Cells Counted (n) Cultures (n)
Naturally occuring
 1 2.5 × 1011 94.1 ± 1.9% 739 4 79.6 ± 4.1% 295 3
 2 2.0 – 2.5 × 1011 83.8 ± 4.0% 736 5 53.6 ± 9.0% 533 4
 5 2.5 × 1011 toxic 2 -
2.5 × 109 48.4 ± 9.4% 1074 3 61.9 ± 17.7% 227 3
 6 2.5 × 1011 toxic 3 -
6.7 × 1010 toxic 6 -
2.5 – 5.0 × 109 72.1 ± 19.1% 822 3 84.7 ± 10.4% 264 3
 7 2.5 × 1011 88.0 ± 4.3% 785 5 74.4 ± 12.8% 392 4
 8 2.5 × 1011 94.2 ± 1.9% 599 5 63.2 ± 13.9% 412 4
 9 2.5 × 1011 79.5 ± 5.8% 985 4 43.2 ± 2.2% 320 3
Engineered variants
 2.hu29R 3.1 × 1011 0% 3 -
 6.1 5.0 × 1011 91.3 ± 1.7% 491 3 64.1 ± 4.1% 399 3
 6.2 5.0 × 1010 toxic 3 -
 6.1.2 5.0 × 1011 94.1 ± 2.8% 443 3 85.1 ± 2.5% 282 3

All vectors listed in this table encoded CMV-GFP. Vectors were added to cells at 7DIV; counts were performed at 21DIV.